These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 7962300

  • 1. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
    Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):934-9. PubMed ID: 7962300
    [Abstract] [Full Text] [Related]

  • 2. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
    Mastorakos G, Chrousos GP, Weber JS.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1690-4. PubMed ID: 8263159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F, Velut JG, Guillaume V, Sauze N, Orsoni JC, Gaillard RC, Oliver CC.
    Neuroendocrinology; 1999 May; 69(5):352-9. PubMed ID: 10343176
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.
    Späth-Schwalbe E, Born J, Schrezenmeier H, Bornstein SR, Stromeyer P, Drechsler S, Fehm HL, Porzsolt F.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1212-4. PubMed ID: 7962296
    [Abstract] [Full Text] [Related]

  • 7. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL, Irvine CH, Livesey JH, Donald RA.
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men.
    Rubin RT, Sekula LK, O'Toole S, Rhodes ME, Czambel RK.
    Neuropsychopharmacology; 1999 May; 20(5):434-46. PubMed ID: 10192824
    [Abstract] [Full Text] [Related]

  • 10. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
    Beishuizen A, Thijs LG.
    J Endotoxin Res; 2003 May; 9(1):3-24. PubMed ID: 12691614
    [Abstract] [Full Text] [Related]

  • 11. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP, Clarke IJ, Funder JW, Engler D.
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [Abstract] [Full Text] [Related]

  • 12. Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans.
    Nye EJ, Hockings GI, Grice JE, Torpy DJ, Walters MM, Crosbie GV, Wagenaar M, Cooper M, Jackson RV.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):812-7. PubMed ID: 9062488
    [Abstract] [Full Text] [Related]

  • 13. The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis.
    Raab C, Weidmann E, Schmidt A, Bergmann L, Badenhoop K, Usadel KH, Haak T.
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):37-44. PubMed ID: 10341854
    [Abstract] [Full Text] [Related]

  • 14. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R.
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [Abstract] [Full Text] [Related]

  • 15. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL, Irvine CH.
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM.
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [Abstract] [Full Text] [Related]

  • 17. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
    Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
    [Abstract] [Full Text] [Related]

  • 18. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
    Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.